Callan Family Office’s Copart CPRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Sell
9,257
-8,649
-48% -$279K 0.01% 1054
2026
Q1
$594K Sell
17,906
-881
-5% -$33.1K 0.01% 715
2025
Q4
$736K Buy
18,787
+9,117
+94% +$378K 0.02% 645
2025
Q3
$435K Sell
9,670
-14,308
-60% -$674K 0.01% 572
2025
Q2
$1.18M Buy
23,978
+17,692
+281% +$990K 0.04% 364
2025
Q1
$356K Buy
6,286
+58
+0.9% +$3.26K 0.03% 391
2024
Q4
$357K Buy
+6,228
New +$355K 0.02% 443

Other funds holding CPRT

Callan Family Office's CPRT Position: Q2 2026 in Review

Callan Family Office reduced its Copart (CPRT) stake by 48% in Q2 2026, selling an estimated $279K and leaving 9,257 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #1054.

Callan Family Office first reported a position in CPRT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.18M in Q2 2025. 1,062 funds tracked by Wall St. Rank hold CPRT as of Q2 2026.

  • Callan Family Office held 9,257 shares of Copart worth $261K as of Q2 2026.
  • Callan Family Office sold 8,649 Copart shares in Q2 2026, an estimated $279K.
  • Copart made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #1054 holding.
  • Callan Family Office first reported a position in Copart in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Copart position peaked at $1.18M in Q2 2025.
  • 1,062 funds tracked by Wall St. Rank held Copart as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.